Claudia Espinosa-Garcia

Claudia Espinosa-Garcia is an Associate Research Scientist in the Department of Neurology at Yale School of Medicine, where she works in the Rangaraju Lab focusing on neuroinflammation, cell-type specific proteomics, and neurological disorders. Her research bridges molecular neuroscience with clinical implications for neurodegenerative conditions.

Education:

• PhD in Biomedical Sciences, National Autonomous University of Mexico (2014)
• MSc in Experimental Biology, Metropolitan Autonomous University (2009)
• BSc in Experimental Biology, Metropolitan Autonomous University (2007)

Dr. Espinosa-Garcia's research focuses on understanding how neuroinflammatory processes, particularly microglial responses, contribute to brain disorders including epilepsy, Alzheimer's disease, and ischemic injury. Her work employs advanced proteomic techniques to investigate cell-type and subcellular-specific changes in neurological conditions, with particular emphasis on how comorbidities like chronic stress exacerbate pathological processes. She has pioneered approaches using native-state proteomics to study specific neuronal populations in vivo without artificial manipulation.

Analysis of her publication record reveals a consistent trajectory from studying stress effects on neuroinflammation to developing innovative proteomic methodologies for cell-type specific analysis. Her work spans Alzheimer's disease, epilepsy, ischemic brain injury, and the intersection of stress with neurological disorders. Recent publications demonstrate increasing sophistication in subcellular proteomic analysis, particularly regarding how different cellular compartments respond to neuroinflammatory challenges.

Scientific Awards:

• NARSAD Young Investigator Grant (2020) from Brain & Behavior Research Foundation
• American Heart Association Postdoctoral Fellowship (2017)

Dr. Espinosa-Garcia has secured significant grant funding for her research on neuroinflammation and neurological disorders. Her work in the Rangaraju Lab involves developing and applying cutting-edge proteomic techniques to understand neurological conditions at unprecedented cellular resolution. She has contributed to methodological advances in cell-type specific protein analysis that have broader applications across neuroscience research.

As a member of the Rangaraju Lab at Yale School of Medicine, Dr. Espinosa-Garcia contributes to a research environment focused on innovative approaches to studying brain function and pathology. Her work on native-state proteomics represents a significant technical advancement in the field, allowing researchers to examine cell-specific proteomes in their natural context without the artifacts introduced by traditional cell isolation methods.